Home > Insider Trading > Filing (0001493152-25-005942)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642380	Oncocyte Corp	OCX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1167028	W Patrick Smith	C/O Oncocyte Corporation 15 Cushing Irvine CA 92618		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2025-02-07	1,077,600	$2.05	2,872,671	No	4	P	Indirect	See footnote
Common Stock, No Par Value	Acquisiton	2025-02-07	385,814	$2.05	3,258,485	No	4	J	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	J	Indirect	See footnote

Footnotes

Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.
The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.
Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a registered direct offering pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.